- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x R0P: 1-cyclopropyl-3-({1-[3-(methylsulfonyl)propyl]-1H-pyrrolo[3,2-c]pyridin-2-yl}methyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one(Non-covalent)
- 3 x CL: CHLORIDE ION(Non-functional Binders)
- 18 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 4 residues within 4Å:- Chain A: L.273, N.276, N.277, R.364
Ligand excluded by PLIPSO4.4: 5 residues within 4Å:- Chain A: K.427, N.444, K.445, G.446, K.461
Ligand excluded by PLIPSO4.5: 5 residues within 4Å:- Chain A: S.443, K.445, G.464, K.465, S.466
Ligand excluded by PLIPSO4.6: 5 residues within 4Å:- Chain A: F.137, G.139, P.353, Q.354
- Ligands: R0P.1
Ligand excluded by PLIPSO4.7: 4 residues within 4Å:- Chain A: V.192, L.193, D.194, K.226
Ligand excluded by PLIPSO4.8: 2 residues within 4Å:- Chain A: K.293, E.294
Ligand excluded by PLIPSO4.11: 4 residues within 4Å:- Chain B: L.273, N.276, N.277, R.364
Ligand excluded by PLIPSO4.12: 5 residues within 4Å:- Chain B: K.427, N.444, K.445, G.446, K.461
Ligand excluded by PLIPSO4.13: 5 residues within 4Å:- Chain B: S.443, K.445, G.464, K.465, S.466
Ligand excluded by PLIPSO4.14: 5 residues within 4Å:- Chain B: F.137, G.139, P.353, Q.354
- Ligands: R0P.9
Ligand excluded by PLIPSO4.15: 4 residues within 4Å:- Chain B: V.192, L.193, D.194, K.226
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain B: K.293, E.294
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain C: L.273, N.276, N.277, R.364
Ligand excluded by PLIPSO4.20: 5 residues within 4Å:- Chain C: K.427, N.444, K.445, G.446, K.461
Ligand excluded by PLIPSO4.21: 5 residues within 4Å:- Chain C: S.443, K.445, G.464, K.465, S.466
Ligand excluded by PLIPSO4.22: 5 residues within 4Å:- Chain C: F.137, G.139, P.353, Q.354
- Ligands: R0P.17
Ligand excluded by PLIPSO4.23: 4 residues within 4Å:- Chain C: V.192, L.193, D.194, K.226
Ligand excluded by PLIPSO4.24: 2 residues within 4Å:- Chain C: K.293, E.294
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vendeville, S. et al., Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus. J.Med.Chem. (2020)
- Release Date
- 2020-05-27
- Peptides
- Prefusion RSV F (DS-Cav1): ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
FC
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x R0P: 1-cyclopropyl-3-({1-[3-(methylsulfonyl)propyl]-1H-pyrrolo[3,2-c]pyridin-2-yl}methyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one(Non-covalent)
- 3 x CL: CHLORIDE ION(Non-functional Binders)
- 18 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vendeville, S. et al., Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus. J.Med.Chem. (2020)
- Release Date
- 2020-05-27
- Peptides
- Prefusion RSV F (DS-Cav1): ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
FB
FC
F